JUN and melanoma: In this study, we found that Ailanthone (AIL) was a potential inhibitor of c-Jun by a ligand-based QSAR model combined with a structure-based docking approach from a traditional Chinese medicine (TCM) library, which exhibited remarkable antitumor activity against melanoma cells.